Selective inhibition of platelet-derived thromboxane A2 in patients with lupus anticoagulant using low doses aspirin as assessed by enzyme immunoassay.
Lellouche
F
F
U 150 INSERM, Hôpital Lariboisière, Paris, France.
Falcon
C
C
Carreras
L
L
Maclouf
J
J
D001241:Aspirin / Q000494:pharmacology*; D001323:Autoantibodies / Q000276:immunology*; D001779:Blood Coagulation Factors / Q000276:immunology*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007124:Immunoenzyme Techniques; D016682:Lupus Coagulation Inhibitor; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors* / Q000096:biosynthesis
D001323:Autoantibodies; D001779:Blood Coagulation Factors; D016682:Lupus Coagulation Inhibitor; D013928:Thromboxane A2; D001241:Aspirin